Express Pharma February 2024
India's Foremost Pharma & Biotech Magazine ~ Cell And Gene Therapies: The Next Frontier?
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Glenmark partners with Pfizer to launch Abrocitinib in India
When launched in India, it will be co-marketed under the brand names JABRYUS and CIBINQO by Glenmark and Pfizer respectively
AstraZeneca and Sanofi Beyfortus to dominate RSV market in China: GlobalData
In 2017, Sanofi entered into a collaboration agreement with MedImmune (AstraZeneca) to jointly develop and commercialise Beyfortus
Masterclass with Masihuddin Jaigirdar, Pharmaceutics Expert | Session 1 | Regulatory Watch
The world of pharma regulations is constantly evolving, presenting new challenges and opportunities. In this ever-changing…
Masterclass with Masihuddin Jaigirdar, Pharmaceutics Expert | Session 2 | Regulatory Watch
The world of pharma regulations is constantly evolving, presenting new challenges and opportunities. In this ever-changing…
Masterclass with Masihuddin Jaigirdar, Pharmaceutics Expert | Session 3 | Regulatory Watch
The world of pharma regulations is constantly evolving, presenting new challenges and opportunities. In this ever-changing…
Jubilant Pharma to sell its 25.8 per cent stake in Sofie Biosciences for $139.43 mn
Of this, $113.63 million is expected to be received upon completion of the merger while receipt of balance sum of $25.8 million is…
Glenmark and Ichnos launch Ichnos Glenmark Innovation to accelerate new drug discovery in cancer…
The newly formed IGI features a pipeline of three innovative oncology molecules targeting multiple myeloma, acute myeloid leukemia…
Zydus launches Rexigo, oral once-a-day pill to treat advanced prostate cancer
Relugolix is reportedly the only oral option of ADT drugs known as gonadotropin releasing hormone (GnRH) analogues
Orchid Pharma gets EMA approval for Exblifep
Exblifep has received EMA's recommendation for marketing authorization for use in treatment of complicated urinary tract…